A world-first clinical trial published in JAMA could provide an easy way to save several units of blood every year in Canada and much more worldwide. The trial, which involved more than 27,000 patients in 25 adult intensive care units (ICUs) across Canada, showed that taking less blood for lab tests using “small-volume” tubes reduced the need for almost one blood transfusion for every 10 patients.
Most hospitals use standard tubes that automatically draw 4–6 ml of blood, but a typical laboratory test requires less than 0.5 ml of blood, meaning the rest (more than 90 percent) is wasted. Commercially available small-volume tubes have a weaker vacuum inside that automatically draws up to half as much blood.
“While the amount of blood drawn per tube is relatively small, ICU patients typically require multiple blood samples taken multiple times every day. This can add up to significant blood loss that contributes to anemia, or low red blood cells. ICU patients are unable to produce more red blood cells to correct for this blood loss and often require treatment with a blood transfusion,” said senior author Deborah Siegal, MD, MSc, FRCPC, a scientist and hematologist at The Ottawa Hospital Research Institute, who led the trial, which was coordinated, sponsored and funded by the Population Health Research Institute (PHRI) in Hamilton, ON—a joint institute of McMaster University and Hamilton Health Sciences.
“This trial showed that we can save one blood transfusion for every 10 ICU patients by simply switching to small-volume tubes for blood collection,” said Siegal. “At a time when everyone is trying to find ways to make health care more sustainable and preserve our supply of blood products, this study provides a simple solution that can be implemented without additional cost or negative effects. The patients in our study received over 36,000 blood transfusions. With small-volume tubes, we may have saved about 1,500 units of blood.”
Battling blood shortages and anemia
In Canada, the costs associated with blood transfusions ($450 per unit of blood, with additional costs to hospitals for testing, preparation, storage, etc.) are covered by the public health system. Blood donors are not paid, and blood conservation is a priority as shortages are common.
The study also has important implications for patients, as low red blood cells (RBCs), or anemia, can leave patients feeling tired and weak and is associated with can lead to other complications and longer hospital stays. While blood transfusions can usually correct anemia, there can be rare side effects, such as difficulty breathing, allergic reactions, and infections.
The trial employed an innovative design that involved randomizing different ICUs to use either small-volume blood collection tubes or regular tubes for different periods, before switching to the other tubes. The researchers used electronic medical records to track how many blood transfusions were given to each patient, excluding patients who stayed for less than 48 hours in the ICU.
While previous observational studies have supported the use of small-volume tubes, this is the first clinical trial to rigorously test them in the hospital setting. In addition to finding that the small-volume tubes reduced anemia and the need for blood transfusions, the trial also confirmed that the smaller volume of blood did not compromise laboratory testing. When the researchers excluded results from five months when the COVID-19 pandemic peaked, the trends were the same but not statistically significant.
- This press release was originally published on The Ottawa Hospital Research Institute website